AVS-300

N/A

Report date: 2026/05/13 09:17:09

Base Information

Drug NameAVS-300

Drug Alias NamemRNA based TEM1 cancer vaccineAVS-300

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAvstera Therapeutics Corp

China Registration ClassN/A

Develop Information

Active CompaniesAvstera Therapeutics Corp

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A